Brief: Impedimed Executing Towards Profitability In Oncology

ImpediMed

22/08/2023 02:24

Aug 22 (Reuters) - ImpediMed Ltd  IPD.AX :
    * EXECUTING TOWARDS PROFITABILITY IN ONCOLOGY
    * CONFIRM THERE IS NO INTENTION TO LEAVE ASX OR SEEK LISTING
ON
NASDAQ OR ANY OTHER FOREIGN EXCHANGE

Source text for Eikon:  ID:nASX6RVFSW 
Further company coverage:  IPD.AX 

 ((Reuters.Briefs@thomsonreuters.com;))